Clinical trial
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of…
NCT00064402 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00064402 |
|---|---|
| Title | Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD |
| Official title | A Double-Blind, Double-Dummy, Randomized, Placebo- and Active-Controlled, Multicenter, Parallel-Group Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema |
| Intervention type | Drug |
| Interventions | arformoterol tartrate inhalation solution, Salmeterol, Placebo |
| Enrollment | 741 |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Jul 9, 2003 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: